These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Plasma fibronectin and alcoholic liver disease].
    Author: Ricciardi R, Restuccia G, Chindemi G.
    Journal: Quad Sclavo Diagn; 1987 Jun; 23(2):153-63. PubMed ID: 3451292.
    Abstract:
    The authors examined, in 58 chronic alcoholics, the behaviour of plasma fibronectin, SGPT and seric albumin. Among the patients, ten were without liver damage while the others were affected with alcoholic liver disease at different stages, such as steatosis (12), steatofibrosis (14), evolutive chronic hepatitis (10), cirrhosis (12). The levels of plasma fibronectin appeared significantly increased in the cases with steatofibrosis, evolutive chronic hepatitis and cirrhosis; unimportant changes were noted in the cases with steatosis. SGPT always resulted increased, showing the existence of cytolysis related with plasma fibronectin levels, while seric albumin was constantly reduced with negative ratio to fibronectin levels, except in cases of decompensated cirrhosis. The authors believe that the monitoring of plasma fibronectin in chronic alcoholics may be a suitable means to reveal an increased liver fibrosis.
    [Abstract] [Full Text] [Related] [New Search]